Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
APN:JSE
Aspen Pharmacare Holdings Ltd
ZAC 13 900,00
0,00%
(0,00) 1D
30 Apr., 17:02:52 GMT+2  ·   ZAC
All symbols
SymbolPriceChange% Change
Generating top insights for APN...
Mkt. cap
62,03 mjd
Avg. vol.
1,14 m
Volume
0,00
Dividend
1,52%
Quarterly dividend
ZAC 52,75
Ex dividend date
01 Okt. 2025
52-wk high
ZAC 14 458,00
52-wk low
ZAC 9 070,00
EPS
-ZAC 4,51
Shares outstanding
446,25 m
No. of employees
9 k
News stories
From sources across the web
Profile
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
About Aspen Pharmacare Holdings Ltd
CEOStephen Saad
Employees9,34 k
Founded1850
HeadquartersDurban, KwaZulu-Natal, Suid-Afrika
SectorPharmaceutical industry
Websiteaspenpharma.com
Last report
11 Feb. 2026
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-/ -ZAR
Revenue / Estimate
8,54 mjd/ (- est.)ZAR
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in ZAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ZAR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
10,70 mjd
10,70 mjd
8,54 mjd
8,54 mjd
Cost of goods sold
6,40 mjd
6,40 mjd
4,81 mjd
4,81 mjd
Cost of revenue
6,40 mjd
6,40 mjd
4,81 mjd
4,81 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,79 mjd
2,79 mjd
2,17 mjd
2,17 mjd
Operating expense
2,75 mjd
2,75 mjd
2,82 mjd
2,82 mjd
Total operating expenses
9,15 mjd
9,15 mjd
7,63 mjd
7,63 mjd
Operating income
1,55 mjd
1,55 mjd
910,00 m
910,00 m
Other non operating income
-150,00 m
-150,00 m
-9,50 m
-9,50 m
EBT including unusual items
-1,65 mjd
-1,65 mjd
577,50 m
577,50 m
EBT excluding unusual items
1,12 mjd
1,12 mjd
577,50 m
577,50 m
Income tax expense
81,50 m
81,50 m
144,50 m
144,50 m
Effective tax rate
-4,93%
-4,93%
25,02%
25,02%
Other operating expenses
-39,50 m
-39,50 m
643,50 m
643,50 m
Net income
-1,74 mjd
-1,74 mjd
736,00 m
736,00 m
Net profit margin
-16,22%
-16,22%
8,62%
8,62%
Earnings per share
-
-
-
-
Interest and investment income
93,00 m
93,00 m
83,50 m
83,50 m
Interest expense
-445,50 m
-445,50 m
-426,50 m
-426,50 m
Net interest expenses
-352,50 m
-352,50 m
-343,00 m
-343,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,79 mjd
1,79 mjd
1,39 mjd
1,39 mjd
Gain or loss from assets sale
11,00 m
11,00 m
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer